ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,267Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 247

$820K Total Retail Price of All Prescriptions

Rank: 6 out of 247

498 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

0% of this provider’s 9,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 484 399 1 2
OMEPRAZOLE 481 379 2 4
SIMVASTATIN 473 369 3 1
AMLODIPINE BESYLATE 393 348 4 6
HYDROCHLOROTHIAZIDE 358 332 5 9
METOPROLOL TARTRATE 320 300 6 7
ATORVASTATIN CALCIUM 295 261 7 8
FUROSEMIDE 252 230 8 5
SERTRALINE HCL 251 188 9 16
LEVOTHYROXINE SODIUM 228 192 10 3
METFORMIN HCL 225 148 11 12
WARFARIN SODIUM 204 200 12 13
SPIRIVA 199 180 13 26
METOPROLOL SUCCINATE 189 179 14 14
HYDROCODONE-ACETAMINOPHEN 187 141 S3 15 11
GLIPIZIDE 179 125 16 43
ZOLPIDEM TARTRATE 178 162 17 24
TRAZODONE HCL 160 117 18 28
TRAMADOL HCL 160 128 18 25
GABAPENTIN 153 137 20 17
LOSARTAN POTASSIUM 150 137 21 15
KLOR-CON M20 123 115 22 44
ADVAIR DISKUS 119 96 23 18
FLUTICASONE PROPIONATE 114 87 24 37
POTASSIUM CHLORIDE 114 105 24 36
LOVASTATIN 97 93 26 22
DIOVAN 97 91 26 38
PRAVASTATIN SODIUM 95 90 28 23
LIPITOR 93 72 29 50
ALLOPURINOL 92 86 30 33
PROAIR HFA 92 52 30 29
TAMSULOSIN HCL 91 88 32 31
SYMBICORT 89 83 33 92
ATENOLOL 89 84 33 10
LANTUS 89 69 33 39
RANITIDINE HCL 86 49 36 34
ISOSORBIDE MONONITRATE ER 79 79 37 40
HUMALOG 76 48 38 78
VENLAFAXINE HCL ER 74 27 39 64
BENAZEPRIL HCL 74 67 39 80
PANTOPRAZOLE SODIUM 72 65 41 19
CRESTOR 72 55 41 30
PEN NEEDLE 70 60 43 79
KLOR-CON M10 69 69 44 95
MIRTAZAPINE 67 54 45 46
DONEPEZIL HCL 63 63 46 35
PREDNISONE 60 54 47 21
OXYCODONE-ACETAMINOPHEN 56 41 S2 48 87
PROPRANOLOL HCL 56 50 48 147
ROPINIROLE HCL 53 38 50 69
BENICAR 53 53 50 116
ESCITALOPRAM OXALATE 51 35 52 65
INSULIN SYRINGE 50 25 53 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.